However, OLIG2-expressing cells are also found in other subgroups [23] and that OLIG2 may contribute to tumor heterogeneity across MB disease subsets [50], which may explain the response observed in the Group-3 Neo-113 model. Here, OLIG2 is linked to neoplasm.